Microdosing of GLP-1's The Rationale for Microdosing While GLP-1 receptor agonists (GLP-1 RAs) are effective treatments, higher doses can cause gastrointestinal side effects such as nausea and vomiting
The stronger goal is to build a supervised plan that helps preserve muscle, reduce metabolic risk, manage side effects, and maintain healthier habits after the most active weight-loss phase slows down
This is one of the most misleading things about how these patches are marketed
Its always best to confirm with your medical team before making any adjustments to your schedule
Read about the TRANSCEND-T2D-2 trial
Arillotta D, Floresta G, Guirguis A, Corkery JM, Catalani V, Martinotti G, Sensi SL, Schifano F